Target intelligence / Profile preview

Transmembrane channel-like protein 2 (TMC2)

Target
TMC2
Molecular classification
Ion channel, Mechanotransduction complex protein, Membrane protein
01

Overview

Transmembrane channel-like protein 2 (TMC2) is an evolutionarily conserved membrane protein that functions as a probable pore-forming subunit of a mechanosensitive ion channel complex[2][3]. In vertebrates, TMC2 (alongside TMC1) is crucial for mechanotransduction in auditory hair cells, facilitating the conversion of sound-induced mechanical force into electrical signals required for hearing[3]. Structurally, TMC2 is a dimeric membrane protein with 10 transmembrane helices, and it complexes with auxiliary proteins such as TMIE and CALM-1[1][2]. It is widely expressed in sensory systems and is essential for normal auditory function, with mutations linked to hereditary hearing loss (though more direct links are established for TMC1). The gating and ion selectivity mechanisms, as well as downstream signaling, are the subject of extensive research, but the protein is considered a member of a novel ion channel family involved in fundamental sensory processes[2][3]. No clinically approved drugs are known to act on TMC2, and there are no established biomarkers or clinical safety concerns recognized to date[3].

Other names
Transmembrane channel-like 2TMC2C20orf145UNQ907/PRO1928dJ686C3.3Transmembrane cochlear-expressed protein 2transmembrane cochlear-expressed gene 2
02

Mechanism of action

Not established; no approved drugs directly target TMC2

03

Biological functions

Mechanosensory transduction (conversion of mechanical stimuli into electrical signals)Auditory mechanotransduction (in hair cells)Cation ion transportSensorimotor signaling (across taxa)
04

Disease associations

Hearing loss (mutations implicated in hereditary deafness)Other (evidence for involvement in various sensorimotor functions)
05

Safety considerations

No notable safety concerns reported; main challenges are functional reconstitution and specificity in targeting for therapy

Beyond the preview

Go deeper on Transmembrane channel-like protein 2 (TMC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane channel-like protein 2 (TMC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call